Sunday 13 July 2025
Internal Reference Number: FOI_8526
Date Request Received: 21/03/2025 00:00:00
Date Request Replied To: 07/05/2025 00:00:00
This response was sent via: By Email
Request Summary: Treatment for Myelofibrosis
Request Category: Companies
| Question Number 1: HSJ Information are researching the treatment of myeloproliferative neoplasms. We would greatly appreciate if you could answer the following questions: Please provide the total number of patients treated in the last 6 months (1st September 2024 till 28th February 2025) for: • Polycythaemia Vera (ICD10 code D45) • Myelofibrosis (ICD10 code D47.4) • Myelofibrosis (ICD10 code D47.4) patients aged 65 and older | |
| Answer To Question 1: Please see our response in the Excel spreadsheet attached. To accompany this answer to question 1 please also see the documents listed below:  12851 - FOI_8526 - Treatment for Myelofibrosis FOR ISSUE.xlsx | |
| Question Number 2: How many patients were treated in the past 6 months (1st September 2024 till 28th February 2025) for any disease with: • Ruxolitinib • Fedratinib • Momelotinib | |
| Answer To Question 2: Ruxolitinib - 11 patients Fedratinib - 0 patients Momelotinib - 7 patients. | |
| Question Number 3: How many patients were treated with Ruxolitinib in the past 6 months (1st September 2024 till 28th February 2025) for the following diseases? • Myelofibrosis (ICD10 code D47.4) • Polycythaemia Vera (ICD10 code D45) • Other/Unknown | |
| Answer To Question 3: Myelofibrosis - 8 patients Polycythaemia Vera - <5 patients Other/Unknown - 0 patients | |
| Question Number 4: How many myelofibrosis (ICD10 code D47.4) patients has your trust diagnosed in the past 3 years? • Of these patients, how many were treated in the past 6 months with Hydroxycarbamide? • Of these patients, how many were treated in the past 6 months with Interferon therapy? • Of these patients, how many have received no active treatment in the past 6 months? 6 months = (1st September 2024 till 28th February 2025) | |
| Answer To Question 4: Of these patients, how many were treated in the past 6 months with Hydroxycarbamide? - <5 patients Of these patients, how many were treated in the past 6 months with Interferon therapy? - < 5 patients Of these patients, how many have received no active treatment in the past 6 months? - <5 patients | |
| Question Number 5: Does your trust participate in any clinical trials for the treatment of myelofibrosis? If so, can you please provide the name of each trial along with the number of patients taking part. | |
| Answer To Question 5: NO | |
| Please see Attachments: | |
| To return to the list of all the FOI requests please click here | |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
